GLP-1 medication can also put people at risk of developing: thyroid tumors, including cancer acute pancreatitis gallbladder injury acute kidney injury vision problems diabetic retinopathy The price people pay for GLP-1 pills will depend on their health insurance and whether they are eligible for any savings programs
November 2025: FDA approved expanded Zepbound (tirzepatide) indication for moderate-to-severe obstructive sleep apnea in adults with obesity, following SURMOUNT-OSA trial data showing 62.8% reduction in apnea-hypopnea index the first drug approval for sleep apnea treatment
The drug is often prescribed in conjunction with physical therapy, enabling patients to engage more fully in rehabilitation exercises that can improve their overall mobility and quality of life
Recognizing the warning signs can save lives
When combined with dry mouth or poor nutrition, the effects can be more noticeable
This means fewer cravings, more stable energy levels, and a healthier, more sustainable approach to fat loss